Articles by David F. Archer

1 2 3 4 5

In Reply

Archer, David F.; Constantine, Ginger D.; Simon, James; More

Menopause. 24(8):988-989, August 2017.

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal...

Constantine, Ginger D.; Simon, James A.; Pickar, James H.; More

Menopause. 24(4):409-416, April 2017.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome...

Labrie, Fernand; Archer, David F.; Koltun, William; More

Menopause. 23(3):243-256, March 2016.

  • Editorial

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women

Portman, David J.; Labrie, Fernand; Archer, David F.; More

Menopause. 22(12):1289-1295, December 2015.

  • Editorial

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

Archer, David F.; Labrie, Fernand; Bouchard, Céline; More

Menopause. 22(9):950-963, September 2015.

Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial

Pinkerton, JoAnn V.; Archer, David F.; Guico-Pabia, Christine J.; More

Menopause. 20(1):38-46, January 2013.

Transdermal estradiol gel for the treatment of symptomatic postmenopausal women

Archer, David F.; Pickar, James H.; MacAllister, Dipali C.; More

Menopause. 19(6):622-629, June 2012.

  • Editorial

Efficacy and tolerability of local estrogen therapy for urogenital atrophy

Archer, David F.

Menopause. 17(1):194-203, January 2010.

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis

Pinkerton, JoAnn V.; Archer, David F.; Utian, Wulf H.; More

Menopause. 16(6):1102-1108, November-December 2009.

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

Archer, David F.; Pinkerton, JoAnn V.; Utian, Wulf H.; More

Menopause. 16(6):1109-1115, November-December 2009.

Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women

Naunton, Mark; Al Hadithy, Asmar F. Y.; Brouwers, Jacobus R. B. J.; More

Menopause. 13(3):517-527, May-June 2006.

Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells

Mirkin, Sebastian; Mahony, Mary C.; Archer, David F.

Menopause. 11(1):82-88, January-February 2004.

1 2 3 4 5